SIMILAR PATTERNS OF AMINO ACIDS FOR 4LCA_A_ADNA401_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j0n XANTHAN LYASE

(Bacillus sp.
GL1)
PF02278
(Lyase_8)
PF02884
(Lyase_8_C)
PF08124
(Lyase_8_N)
4 SER A 494
LEU A 681
TYR A 390
PRO A 722
None
1.34A 4lcaA-1j0nA:
0.0
4lcaA-1j0nA:
18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sy7 CATALASE 1

(Neurospora
crassa)
PF00199
(Catalase)
PF01965
(DJ-1_PfpI)
PF06628
(Catalase-rel)
4 SER A 378
LEU A 372
TYR A 379
PRO A 179
HDD  A1880 ( 2.7A)
None
HDD  A1880 ( 4.0A)
None
1.50A 4lcaA-1sy7A:
3.8
4lcaA-1sy7A:
18.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vcz RNASE NGR3

(Nicotiana
glutinosa)
PF00445
(Ribonuclease_T2)
4 SER A 101
LEU A  60
TYR A 108
PRO A  51
None
1.41A 4lcaA-1vczA:
undetectable
4lcaA-1vczA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1z1d LARGE T ANTIGEN

(Macaca mulatta
polyomavirus 1)
PF02217
(T_Ag_DNA_bind)
4 SER B  61
LEU B  18
TYR B  34
PRO B 112
None
1.42A 4lcaA-1z1dB:
undetectable
4lcaA-1z1dB:
15.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xf2 CATALASE

(Penicillium
janthinellum)
PF00199
(Catalase)
PF06628
(Catalase-rel)
4 SER A 350
LEU A 344
TYR A 351
PRO A 151
HDD  A 690 (-2.8A)
None
HDD  A 690 (-3.7A)
None
1.46A 4lcaA-2xf2A:
4.5
4lcaA-2xf2A:
20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3asa LL-DIAMINOPIMELATE
AMINOTRANSFERASE


(Chlamydia
trachomatis)
PF00155
(Aminotran_1_2)
4 SER A 217
LEU A 289
TYR A  89
PRO A 172
None
1.24A 4lcaA-3asaA:
1.0
4lcaA-3asaA:
23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bg9 PYRUVATE
CARBOXYLASE,
MITOCHONDRIAL


(Homo sapiens)
PF00682
(HMGL-like)
PF02436
(PYC_OADA)
4 SER A 719
LEU A 759
TYR A 723
PRO A 713
None
1.19A 4lcaA-3bg9A:
0.4
4lcaA-3bg9A:
19.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ubo ADENOSINE KINASE

(Sinorhizobium
meliloti)
PF00294
(PfkB)
4 SER A  60
LEU A  37
TYR A 158
PRO A 314
ADN  A 353 (-4.6A)
None
ADN  A 353 (-3.6A)
ADN  A 353 (-4.2A)
1.24A 4lcaA-3uboA:
57.1
4lcaA-3uboA:
71.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ubo ADENOSINE KINASE

(Sinorhizobium
meliloti)
PF00294
(PfkB)
4 SER A  60
LEU A 131
TYR A 158
PRO A 314
ADN  A 353 (-4.6A)
None
ADN  A 353 (-3.6A)
ADN  A 353 (-4.2A)
0.18A 4lcaA-3uboA:
57.1
4lcaA-3uboA:
71.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b2n 70 KDA PROTEIN

(Xanthomonas sp.
35Y)
no annotation 4 SER A 389
LEU A 528
TYR A 367
PRO A 384
None
None
None
HEM  A 701 ( 4.9A)
1.13A 4lcaA-4b2nA:
undetectable
4lcaA-4b2nA:
20.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4e3a SUGAR KINASE PROTEIN

(Rhizobium etli)
PF00294
(PfkB)
4 SER A  58
LEU A  35
TYR A 156
PRO A 312
ADN  A 500 (-3.3A)
None
ADN  A 500 (-3.8A)
ADN  A 500 (-4.3A)
1.29A 4lcaA-4e3aA:
62.5
4lcaA-4e3aA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4e3a SUGAR KINASE PROTEIN

(Rhizobium etli)
PF00294
(PfkB)
4 SER A  58
LEU A 129
TYR A 156
PRO A 312
ADN  A 500 (-3.3A)
None
ADN  A 500 (-3.8A)
ADN  A 500 (-4.3A)
0.54A 4lcaA-4e3aA:
62.5
4lcaA-4e3aA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ph9 PROSTAGLANDIN G/H
SYNTHASE 2


(Mus musculus)
PF00008
(EGF)
PF03098
(An_peroxidase)
4 SER A 456
LEU A 179
TYR A 505
PRO A 219
None
1.47A 4lcaA-4ph9A:
undetectable
4lcaA-4ph9A:
21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q1z PUTATIVE LIPOPROTEIN

(Bacteroides
thetaiotaomicron)
PF16215
(DUF4876)
4 SER A 117
LEU A 257
TYR A 125
PRO A 383
None
1.32A 4lcaA-4q1zA:
undetectable
4lcaA-4q1zA:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tx7 CLASS I CHITINASE

(Vigna
unguiculata)
PF00182
(Glyco_hydro_19)
4 SER A  48
LEU A 106
TYR A  76
PRO A  44
None
1.37A 4lcaA-4tx7A:
undetectable
4lcaA-4tx7A:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h65 PROTECTION OF
TELOMERES PROTEIN 1


(Homo sapiens)
no annotation 4 SER A 421
LEU A 452
TYR A 419
PRO A 409
None
1.39A 4lcaA-5h65A:
undetectable
4lcaA-5h65A:
21.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ip9 DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB2


(Saccharomyces
cerevisiae)
PF00562
(RNA_pol_Rpb2_6)
PF04560
(RNA_pol_Rpb2_7)
PF04561
(RNA_pol_Rpb2_2)
PF04563
(RNA_pol_Rpb2_1)
PF04565
(RNA_pol_Rpb2_3)
PF04566
(RNA_pol_Rpb2_4)
PF04567
(RNA_pol_Rpb2_5)
4 SER B 546
LEU B 521
TYR B 634
PRO B 411
None
1.47A 4lcaA-5ip9B:
undetectable
4lcaA-5ip9B:
15.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5odr HETERODISULFIDE
REDUCTASE, SUBUNIT A


(Methanothermococcus
thermolithotrophicus)
PF07992
(Pyr_redox_2)
PF13187
(Fer4_9)
4 SER A 492
LEU A 185
TYR A 406
PRO A 335
None
FAD  A 701 (-4.4A)
FAD  A 701 (-3.7A)
None
1.43A 4lcaA-5odrA:
5.2
4lcaA-5odrA:
19.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uak CYSTIC FIBROSIS
TRANSMEMBRANE
CONDUCTANCE
REGULATOR


(Homo sapiens)
PF00005
(ABC_tran)
PF00664
(ABC_membrane)
PF14396
(CFTR_R)
4 SER A1058
LEU A 184
TYR A 161
PRO A 499
None
1.44A 4lcaA-5uakA:
1.3
4lcaA-5uakA:
12.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uak CYSTIC FIBROSIS
TRANSMEMBRANE
CONDUCTANCE
REGULATOR


(Homo sapiens)
PF00005
(ABC_tran)
PF00664
(ABC_membrane)
PF14396
(CFTR_R)
4 SER A1058
LEU A1082
TYR A 161
PRO A 499
None
1.46A 4lcaA-5uakA:
1.3
4lcaA-5uakA:
12.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xb7 BETA-GALACTOSIDASE

(Bifidobacterium
animalis)
no annotation 4 SER A 256
LEU A 433
TYR A 250
PRO A 282
None
1.25A 4lcaA-5xb7A:
undetectable
4lcaA-5xb7A:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xyi UNCHARACTERIZED
PROTEIN


(Trichomonas
vaginalis)
PF00163
(Ribosomal_S4)
PF00333
(Ribosomal_S5)
PF01479
(S4)
PF03719
(Ribosomal_S5_C)
4 SER J  96
LEU J  75
TYR J  93
PRO C 188
None
1.20A 4lcaA-5xyiJ:
undetectable
4lcaA-5xyiJ:
19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zvs VP2

(Aquareovirus C)
no annotation 4 SER 2 230
LEU 2 383
TYR 2 271
PRO 2 208
None
1.36A 4lcaA-5zvs2:
undetectable
4lcaA-5zvs2:
14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
8i1b INTERLEUKIN-1 BETA

(Mus musculus)
PF00340
(IL1)
4 SER A  84
LEU A  20
TYR A  24
PRO A  87
None
1.42A 4lcaA-8i1bA:
undetectable
4lcaA-8i1bA:
19.42